Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2018

May 8, 2018

284_dirs_2018-05-08_516a746f-389e-4130-b3a5-b59e55780e3c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2018-05-04

Reporting Person: FRAZIER KENNETH C (Director, Chairman, President & CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-05-04 Stock Option (right to buy) $57.7500 A 475743.0000 Acquired 2028-05-03 Common Stock (475743.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 710697.0630 Direct
Common Stock - 401(k) Plan 3937.2884 Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through April 6, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.

F3: The option vests and becomes exercisable in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.